BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18684922)

  • 1. Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
    Coleman AM; Rendon BE; Zhao M; Qian MW; Bucala R; Xin D; Mitchell RA
    J Immunol; 2008 Aug; 181(4):2330-7. PubMed ID: 18684922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIF family members cooperatively inhibit p53 expression and activity.
    Brock SE; Rendon BE; Xin D; Yaddanapudi K; Mitchell RA
    PLoS One; 2014; 9(6):e99795. PubMed ID: 24932684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.
    Brock SE; Rendon BE; Yaddanapudi K; Mitchell RA
    J Biol Chem; 2012 Nov; 287(45):37917-25. PubMed ID: 22988252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer.
    Wang Q; Wei Y; Zhang J
    Int J Gynecol Cancer; 2017 May; 27(4):634-642. PubMed ID: 28338494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer.
    McClelland M; Zhao L; Carskadon S; Arenberg D
    Am J Pathol; 2009 Feb; 174(2):638-46. PubMed ID: 19131591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).
    Merk M; Zierow S; Leng L; Das R; Du X; Schulte W; Fan J; Lue H; Chen Y; Xiong H; Chagnon F; Bernhagen J; Lolis E; Mor G; Lesur O; Bucala R
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E577-85. PubMed ID: 21817065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIF and D-DT are potential disease severity modifiers in male MS subjects.
    Benedek G; Meza-Romero R; Jordan K; Zhang Y; Nguyen H; Kent G; Li J; Siu E; Frazer J; Piecychna M; Du X; Sreih A; Leng L; Wiedrick J; Caillier SJ; Offner H; Oksenberg JR; Yadav V; Bourdette D; Bucala R; Vandenbark AA
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8421-E8429. PubMed ID: 28923927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
    Guo D; Guo J; Yao J; Jiang K; Hu J; Wang B; Liu H; Lin L; Sun W; Jiang X
    Int J Cancer; 2016 Nov; 139(9):2056-67. PubMed ID: 27434219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.
    Merk M; Mitchell RA; Endres S; Bucala R
    Cytokine; 2012 Jul; 59(1):10-7. PubMed ID: 22507380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.
    Meza-Romero R; Benedek G; Jordan K; Leng L; Pantouris G; Lolis E; Bucala R; Vandenbark AA
    Cytokine; 2016 Dec; 88():62-70. PubMed ID: 27573366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4/MIF axis amplifies tumor growth and epithelial-mesenchymal interaction in non-small cell lung cancer.
    Jäger B; Klatt D; Plappert L; Golpon H; Lienenklaus S; Barbosa PD; Schambach A; Prasse A
    Cell Signal; 2020 Sep; 73():109672. PubMed ID: 32428553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Ahmad A; Siddiquei MM; De Zutter A; Allegaert E; Gikandi PW; De Hertogh G; Van Damme J; Opdenakker G; Struyf S
    Front Immunol; 2019; 10():2752. PubMed ID: 31866994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
    Ren Y; Tsui HT; Poon RT; Ng IO; Li Z; Chen Y; Jiang G; Lau C; Yu WC; Bacher M; Fan ST
    Int J Cancer; 2003 Oct; 107(1):22-9. PubMed ID: 12925952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
    Sugimoto H; Taniguchi M; Nakagawa A; Tanaka I; Suzuki M; Nishihira J
    Biochemistry; 1999 Mar; 38(11):3268-79. PubMed ID: 10079069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.
    Lo MC; Yip TC; Ngan KC; Cheng WW; Law CK; Chan PS; Chan KC; Wong CK; Wong RN; Lo KW; Ng WT; Lee WM; Tsao SW; Kwong LW; Lung ML; Mak NK
    Cancer Lett; 2013 Jul; 335(1):81-92. PubMed ID: 23403077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.
    Simpson KD; Templeton DJ; Cross JV
    J Immunol; 2012 Dec; 189(12):5533-40. PubMed ID: 23125418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity.
    Tilstam PV; Pantouris G; Corman M; Andreoli M; Mahboubi K; Davis G; Du X; Leng L; Lolis E; Bucala R
    J Biol Chem; 2019 Dec; 294(49):18522-18531. PubMed ID: 31578280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.
    Rendon BE; Willer SS; Zundel W; Mitchell RA
    Exp Mol Pathol; 2009 Jun; 86(3):180-5. PubMed ID: 19186177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
    Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
    Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
    Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
    Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.